184 related articles for article (PubMed ID: 23161901)
21. Influence of immunogenicity on the efficacy of long-term treatment with infliximab in rheumatoid arthritis.
Pascual-Salcedo D; Plasencia C; Ramiro S; Nuño L; Bonilla G; Nagore D; Ruiz Del Agua A; Martínez A; Aarden L; Martín-Mola E; Balsa A
Rheumatology (Oxford); 2011 Aug; 50(8):1445-52. PubMed ID: 21427177
[TBL] [Abstract][Full Text] [Related]
22. Analysis of intracellular methotrexate polyglutamates in patients with juvenile idiopathic arthritis: effect of route of administration on variability in intracellular methotrexate polyglutamate concentrations.
Becker ML; van Haandel L; Gaedigk R; Lasky A; Hoeltzel M; Stobaugh J; Leeder JS
Arthritis Rheum; 2010 Jun; 62(6):1803-12. PubMed ID: 20191581
[TBL] [Abstract][Full Text] [Related]
23. Methotrexate polyglutamate levels in circulating erythrocytes and polymorphs correlate with clinical efficacy in rheumatoid arthritis.
Angelis-Stoforidis P; Vajda FJ; Christophidis N
Clin Exp Rheumatol; 1999; 17(3):313-20. PubMed ID: 10410264
[TBL] [Abstract][Full Text] [Related]
24. Response to pneumococcal vaccine in patients with early rheumatoid arthritis receiving infliximab plus methotrexate or methotrexate alone.
Visvanathan S; Keenan GF; Baker DG; Levinson AI; Wagner CL
J Rheumatol; 2007 May; 34(5):952-7. PubMed ID: 17444589
[TBL] [Abstract][Full Text] [Related]
25. High Methotrexate Triglutamate Level Is an Independent Predictor of Adverse Effects in Asian Indian Rheumatoid Arthritis Patients-A Preliminary Study.
Sandhu A; Dhir V; Bhatnagar A; Dhawan V; Kaur J; Sood A; Naidu S; Ahmad S; Varma N; Sharma A; Sharma S
Ther Drug Monit; 2017 Apr; 39(2):157-163. PubMed ID: 28107255
[TBL] [Abstract][Full Text] [Related]
26. Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor alpha monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis.
Maini RN; Breedveld FC; Kalden JR; Smolen JS; Davis D; Macfarlane JD; Antoni C; Leeb B; Elliott MJ; Woody JN; Schaible TF; Feldmann M
Arthritis Rheum; 1998 Sep; 41(9):1552-63. PubMed ID: 9751087
[TBL] [Abstract][Full Text] [Related]
27. Effect of total glucosides of paeony and Tripterygium wilfordii polyglycosides on erythrocyte methotrexate polyglutamates in rats, analysed using ultra-high-performance liquid chromatography-tandem mass spectrometry.
Wu S; Mo L; Ye C; Xun T; Wang X; Lv B; Zhan X; Liu B; Ding Q; Peng J; Chen C; Yang X
J Pharm Pharmacol; 2021 Jul; 73(8):1039-1048. PubMed ID: 33749788
[TBL] [Abstract][Full Text] [Related]
28. Contribution of common polymorphisms in reduced folate carrier and gamma-glutamylhydrolase to methotrexate polyglutamate levels in patients with rheumatoid arthritis.
Dervieux T; Kremer J; Lein DO; Capps R; Barham R; Meyer G; Smith K; Caldwell J; Furst DE
Pharmacogenetics; 2004 Nov; 14(11):733-9. PubMed ID: 15564880
[TBL] [Abstract][Full Text] [Related]
29. Red blood cell methotrexate polyglutamate concentrations in inflammatory bowel disease.
Brooks AJ; Begg EJ; Zhang M; Frampton CM; Barclay ML
Ther Drug Monit; 2007 Oct; 29(5):619-25. PubMed ID: 17898653
[TBL] [Abstract][Full Text] [Related]
30. Differing contribution of methotrexate polyglutamates to adalimumab blood levels as compared with etanercept.
Dervieux T; Kremer JM; Weinblatt ME
Ann Rheum Dis; 2019 Sep; 78(9):1285-1286. PubMed ID: 30885995
[No Abstract] [Full Text] [Related]
31. Impact of concomitant DMARD therapy on adherence to treatment with etanercept and infliximab in rheumatoid arthritis. Results from a six-year observational study in southern Sweden.
Kristensen LE; Saxne T; Nilsson JA; Geborek P
Arthritis Res Ther; 2006; 8(6):R174. PubMed ID: 17121678
[TBL] [Abstract][Full Text] [Related]
32. Folylpolyglutamate synthase is a major determinant of intracellular methotrexate polyglutamates in patients with rheumatoid arthritis.
Yamamoto T; Shikano K; Nanki T; Kawai S
Sci Rep; 2016 Oct; 6():35615. PubMed ID: 27752107
[TBL] [Abstract][Full Text] [Related]
33. A mathematical model of in vivo methotrexate accumulation in acute lymphoblastic leukemia.
Panetta JC; Yanishevski Y; Pui CH; Sandlund JT; Rubnitz J; Rivera GK; Ribeiro R; Evans WE; Relling MV
Cancer Chemother Pharmacol; 2002 Nov; 50(5):419-28. PubMed ID: 12439601
[TBL] [Abstract][Full Text] [Related]
34. Comparison of the response to infliximab or etanercept monotherapy with the response to cotherapy with methotrexate or another disease-modifying antirheumatic drug in patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register.
Hyrich KL; Symmons DP; Watson KD; Silman AJ;
Arthritis Rheum; 2006 Jun; 54(6):1786-94. PubMed ID: 16736520
[TBL] [Abstract][Full Text] [Related]
35. Prediction of the therapeutic response to methotrexate at 24 weeks by methotrexate-polyglutamates concentration in erythrocytes at 8 weeks in patients with rheumatoid arthritis.
Murosaki T; Nagatani K; Sato T; Akiyama Y; Ushijima K; Lefor AK; Fujimura A; Minota S
Mod Rheumatol; 2017 May; 27(3):411-416. PubMed ID: 27435295
[TBL] [Abstract][Full Text] [Related]
36. Adenosine and methotrexate polyglutamate concentrations in patients with juvenile arthritis.
Dolezalová P; Krijt J; Chládek J; Nemcová D; Hoza J
Rheumatology (Oxford); 2005 Jan; 44(1):74-9. PubMed ID: 15454631
[TBL] [Abstract][Full Text] [Related]
37. Treatment of early rheumatoid arthritis: a randomized magnetic resonance imaging study comparing the effects of methotrexate alone, methotrexate in combination with infliximab, and methotrexate in combination with intravenous pulse methylprednisolone.
Durez P; Malghem J; Nzeusseu Toukap A; Depresseux G; Lauwerys BR; Westhovens R; Luyten FP; Corluy L; Houssiau FA; Verschueren P
Arthritis Rheum; 2007 Dec; 56(12):3919-27. PubMed ID: 18050189
[TBL] [Abstract][Full Text] [Related]
38. Changes in biomarkers of inflammation and bone turnover and associations with clinical efficacy following infliximab plus methotrexate therapy in patients with early rheumatoid arthritis.
Visvanathan S; Marini JC; Smolen JS; Clair EW; Pritchard C; Shergy W; Pendley C; Baker D; Bala M; Gathany T; Han J; Wagner C
J Rheumatol; 2007 Jul; 34(7):1465-74. PubMed ID: 17552048
[TBL] [Abstract][Full Text] [Related]
39. Determinants of erythrocyte methotrexate polyglutamate levels in rheumatoid arthritis.
den Boer E; de Rotte MC; Pluijm SM; Heil SG; Hazes JM; de Jonge R
J Rheumatol; 2014 Nov; 41(11):2167-78. PubMed ID: 25225283
[TBL] [Abstract][Full Text] [Related]
40. Methotrexate polyglutamates as a potential marker of adherence to long-term therapy in children with juvenile idiopathic arthritis and juvenile dermatomyositis: an observational, cross-sectional study.
Hawwa AF; AlBawab A; Rooney M; Wedderburn LR; Beresford MW; McElnay JC
Arthritis Res Ther; 2015 Oct; 17():295. PubMed ID: 26493320
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]